Long Covid-Antikörper-Spektrum-Test (AMVAIS)

The Attomarker Multi-Variant Antibody Immunity Spectrum (AMVAIS) test helps us to get one step closer to precision medicine in Long Covid treatments – in this case especially in the area of antiviral therapy. Antibodies are a vital part of our immune systems. When analysing patient antibody responses across a range of COVID variants, it is evident that individual immunity and hence how vulnerable a person is, noticeably varies. In case of the AMVAIS test these individual responses are called immunity endotypes. 

Wir erwarten Ihre Ergebnisse innerhalb von 2 Wochen nach Erhalt der Probe. Sie erhalten: ein Antikörperspektrum und einen Laborbericht.

Prof. Andrew Shaw über die Erstellung von Antikörper-Immunprofilen in Long Covid (Videoquelle: LCCWYCD)

 *Service  provided by Attomarker